tiprankstipranks
Trending News
More News >
Altimmune’s Pemvidutide: A Promising Best-in-Class Therapy with Broad Potential and Strong Buy Rating
PremiumRatingsAltimmune’s Pemvidutide: A Promising Best-in-Class Therapy with Broad Potential and Strong Buy Rating
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Altimmune call volume above normal and directionally bullish
Premium
The Fly
Altimmune call volume above normal and directionally bullish
2M ago
Altimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion
PremiumRatingsAltimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion
2M ago
Altimmune’s Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Altimmune’s Earnings Call: Progress Amid Challenges
2M ago
Altimmune Reports Progress in Clinical Trials and Financials
Premium
Company Announcements
Altimmune Reports Progress in Clinical Trials and Financials
2M ago
Altimmune reports Q4 EPS (33c), consensus (34c)
PremiumThe FlyAltimmune reports Q4 EPS (33c), consensus (34c)
2M ago
Altimmune Expands Board Amid Late-Stage Drug Development
Premium
Company Announcements
Altimmune Expands Board Amid Late-Stage Drug Development
2M ago
Altimmune appoints Teri Lawver, Jerry Durso to board
Premium
The Fly
Altimmune appoints Teri Lawver, Jerry Durso to board
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100